Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

August 15, 2024

Conditions
TamsulosinSilodosinMedical Expulsive Therapy
Interventions
DRUG

Silodosin

Silodosin is an oral medication primarily used to treat benign prostatic hyperplasia (BPH) by relaxing the muscles in the prostate and bladder neck to improve urine flow. It belongs to a class of drugs called alpha-1 adrenergic antagonists, which block receptors responsible for muscle contraction in these areas. This action helps relieve symptoms such as difficulty urinating, urgency, and weak urine stream. Silodosin is taken once daily with food and is known for its high selectivity for alpha-1A receptors, contributing to its effectiveness and safety profile

Trial Locations (1)

54000

Fatima Jinnah Medical University, Lahore

All Listed Sponsors
lead

Fatima Jinnah Medical University

OTHER

NCT06999135 - Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones | Biotech Hunter | Biotech Hunter